SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-000267
Accepted
2022-01-31 00:15:17
Documents
1
Effectiveness Date
2022-01-28
Registration Form
F-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 595
  Complete submission text file 9999999995-22-000267.txt   1741
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-261571 | Film No.: 22571066
SIC: 2835 In Vitro & In Vivo Diagnostic Substances